Previously, Estimated Study Completion Date was February 2012. Now, time to market in EU will probably be delayed. Although, the study design now incorporates planned interim analyses on the primary endpoint, so perhaps a chance for an earlier end of trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.